I
n April 2009, a new subtype of the influenza A virus, pH1N1, caused an epidemic in Mexico (1). On June 11, 2009 , the World Health Organization raised the pandemic alert level for influenza A pH1N1 from phase 5 to phase 6. By July 13, 2009 , 133 countries had officially confirmed 114,008 cases of human influenza A pH1N1 virus infection with 609 deaths (2) (3) (4) (5) .
In Argentina, the curve of the epidemic shows a local onset on May 17, 2009 in Buenos Aires and school-age children were the first cluster of cases. The peak of transmission occurred between June 21-25, 2009 with generalized spread throughout the country (6) . The first death associated with influenza A pH1N1 virus in Argentina was an infant. By June, 33 deaths had been reported (6) .
Few studies have been published either on the reasons for pediatric intensive care unit (PICU) admission of children with influenza A pH1N1 respiratory virus infection or on the clinical and outcome differences between these patients and patients with a non-pH1N1 respiratory virus infection (7) (8) (9) (10) (11) . In this study, we describe the clinical features of patients who had acute lower respiratory tract infection (LRTI) of viral etiology and a confirmed diagnosis of influenza A pH1N1 virus and who were admitted to the PICU. The results are compared with those of patients admitted to the PICU because of acute non-pH1N1 respiratory virus infection.
METHODS

Study Design
The present is a retrospective, observational, and comparative study of patients admitted to the PICU who met the inclusion criteria. The Garrahan Hospital is a universityaffiliated, tertiary-care pediatric hospital located in Buenos Aires, Argentina, and the PICU is a 56-bed multidisciplinary intensive care area.
Inclusion Criteria. 1) Patients who were admitted to the PICU with LRTI due to influenza A virus detected by indirect immunofluorescence antibody testing and the pH1N1 subtype confirmed by real-time reverse transcriptase polymerase chain reaction assay (RT-PCR); 2) patients who were hospitalized in the PICU for other reasons and who developed LRTI due to influenza A virus detected by immunofluorescence antibody testing and the pH1N1 subtype confirmed by RT-PCR; 3) patients who were admitted to the PICU with LRTI due to other viral pathogens as a control group to be compared with patients with influenza A pH1N1 virus infection.
Exclusion Criteria. Patients aged Ͻ1 month old.
The clinical charts of patients admitted to the PICU with LRTI with viral etiology between June 1, 2009 and July 16, 2009 were retrospectively reviewed. The data of the patients enrolled in the study were collected on individual data sheets by the investigators.
Samples were taken from all patients by a nasopharyngeal swab or an endotracheal aspirate in patients who were intubated and tested for viral infection by immunofluorescence antibody at our center. The samples of 2009 that were positive for influenza A were tested for influenza A subtype pH1N1 virus by RT-PCR, according to the guidelines published by the Centers for Disease Control and Prevention (12) . The latter assay was performed at the National Administration of Laboratories and Health Centers "Dr. Carlos G. Malbrá n" (A.N.L.I.S). Influenza A pH1N1 virus infection was defined as a positive result of RT-PCR on a respiratory specimen.
Formation of Two Groups. Group 1 included patients admitted to the PICU with a diagnosis of influenza A pH1N1 virus confirmed by RT-PCR on samples taken between June 1 and July 17, 2009 (epidemiologic wks 21-27). Group 2 included patients infected with non-pH1N1 influenza A virus, influenza B virus, adenovirus, respiratory syncytial virus (RSV), and parainfluenza-3 virus admitted to the PICU during the same period in 2008 plus eight patients admitted in 2009 with an initial positive diagnosis of influenza A virus by immunofluorescence antibody and a subsequent negative result on subtype testing for pH1N1 by RT-PCR (Table 1) .
We describe the clinical features and compare epidemiologic, clinical, and follow-up findings reported in both groups (pH1N1 and non-pH1N1). Children Ͻ1 month of life were excluded from the study.
The following variables were assessed: age, weight, gender, length of hospital stay before PICU admission, length of PICU stay, clinical status before hospital admission, underlying disease, clinical diagnosis on PICU admission, need for mechanical ventilation (MV), highfrequency ventilation, noninvasive positivepressure ventilation, worse values for PaO 2 /FIO 2 ratio and PaCO 2 , most frequent complications, treatment, risk of death using the Pediatric Index of Mortality 2, mortality, and cause of death (13) .
This study was approved by the Research and Development Committee of the Pediatric Hospital "Dr. J. P. Garrahan."
Statistical Analysis
Data analysis was conducted, using STATA 9.0 software (StataCorp LP, College Station, TX). Discrete variables are expressed as counts (percentage) and continuous variables as median and range. For the demographic and clinical characteristics of the patients, differences between groups were assessed, using the chisquare test and Fisher's exact test for categorical variables and the Mann-Whitney U test for continuous variables. A p Յ .05 was considered to be statistically significant.
RESULTS
Clinical Features
Group 1 included 30 children. The most relevant clinical features were: median age, 29.7 months (range, 1.4 -215 months); 17 (59%) patients were Ͼ2 yrs; median weight, 13 kg (range, 2.6 -70 kg); median length of PICU stay, 15.5 days (range, 0 -173 days); and median length of hospital stay before PICU admission, 5 days (range, 0 -103 days). There were no gender differences. Eighty-three percent had an underlying medical condition, most commonly respiratory and neurologic diseases. On admission, 40% of the patients had bilateral pneumonia, 50% had acute respiratory distress syndrome (ARDS), and 30% had shock. In 30% of the patients, a viral coinfection, most frequently RSV, was detected; and in 17% of the patients, a bacterial coinfection was found. Ninety-seven percent of the patients required MV. One child required extracorporeal membrane oxygenation support for 12 days and survived. In this group, using the Pediatric Index of Mortality 2 median of risk of death was calculated as 4.4 (range, 0.2-100) and mortality was 20%. The most common cause of death was hypoxemia due to ARDS.
Group 2 included 62 children with acute LRTI due to RSV (n ϭ 42 patients), non-pH1N1 influenza A virus (n ϭ 10 patients: eight infected in the winter of 2009; two in the winter of 2008), adenovirus (n ϭ 6 patients), influenza B virus (n ϭ 4 patients), parainfluenza virus (n ϭ 1 patient), and RSV associated with adenovirus (n ϭ 1 patient) ( Table 1 ). The most relevant clinical features were: median age, 5.9 months (range, 1.3-166.3 months); 12 (41%) patients were aged Ͼ2 yrs; weight, 7.5 kg (range, 2.6 -50 kg); median length of PICU stay, 13 days (range, 2-199 days); and median length of hospital stay before PICU admission, 2 days (range, 0 -70 days). There were no gender differences. Seventy-nine percent had an underlying medical condition, most commonly respiratory and cardiovascular diseases. On admission, 42% of the patients had bronchiolitis, 15% had bilateral pneumonia, 23% had ARDS, and no patients had shock on admission (Tables 2 and 3) .
Ninety-eight percent of the patients required MV. None of the children required extracorporeal membrane oxygenation support. Pediatric Index of Mortality 2 was 1.85 (range, 0.6 -71), and mortality was 17.7%. The cause of death was hypoxemia (Tables 4 and 5) .
When both groups were compared, the clinical features of group 1 were generally similar to those reported during peak periods of seasonal influenza. Nevertheless, some differences were found. In group 1, a higher number of patients were Ͼ2 yrs of age (p Ͻ .001) concordant with a higher median weight (p Ͻ .001). A high rate of underlying diseases was found in both groups. In group 1, the diseases were more frequently neurologic (p Ͻ .001), respiratory (NS), and hematologic (p Ͻ .01). Patients in group 1 more often presented with bilateral pneumonia (p Ͻ .009), ARDS (p Ͻ .008), and shock (p Ͻ .001) at the time of PICU admission, whereas patients in group 2 more frequently had bronchiolitis (p Ͻ .001). Respiratory complications, such as pneumothorax, were more frequent in group 1 (p Ͻ .001). However, when comparing length of PICU stay, MV, and highfrequency ventilation, no statistically significant differences were found. More patients in group 1 had a PaO 2 /FIO 2 ratio Ͻ200 than group 2, and this difference was statistically significant. The difference in worse PCO 2 values between groups was not statistically significant.
Mortality was similar in both groups-six (20%) patients in group 1 and 11 (17.7%) in group 2-and did not show statistical significance. When comparing mortality between both groups, a shorter length of PICU stay (median, 2.5 days vs. 14 days) and a higher number of patients with shock at the time of admis- sion were observed in the deceased patients in group 1 (4 vs. 0).
Treatment
The treatment used in group 1 was oseltamivir in 100% of the cases, associated with amantadine in 30% to cover resistance of the seasonal influenza A virus in cancer patients. Twenty-eight (93%) children additionally received treatment with antibiotics. Vasoactive and inotropic drugs, mainly dopamine, were used in 25 (83%) children. Volemia expansion was performed in 24 (80%) children, and renal replacement therapy (continuous veno-venous hemofiltration) was provided in two children.
DISCUSSION
In our country, peak occurrence of acute LRTI occurs in the winter months (June-August). According to the statistics of the City of Buenos Aires, LRTI accounts for 31% of the pediatric hospital discharges and is the third most frequent cause of death in children Ͻ1 yr of age (10% to 12%). More than half of the cases occur in the months of June and July. The majority of patients are Ͻ2 yrs of age. One third of the patients with LRTI require MV (6).
During winter months, pediatric wards are monitored for causative agents of LRTI. After the World Health Organization alert, in all cases of LRTI, polymerase chain reaction for subtype detection of pH1N1 has been performed in state hospitals of the City of Buenos Aires and Greater Buenos Aires. Until epidemiologic wk 37, pH1N1 virus and influenza A virus with unknown subtype accounted for 93% of all respiratory viruses reported in persons Ͼ5 yrs of age. However, in children Ͻ5 yrs of age, this percentage was 24%, whereas RSV accounted for 70% of the cases. Additionally, 538 deaths associated with the influenza pandemic have been reported, of whom 47% had a history of chronic disease or risk factors. The last death of a patient with a confirmed diagnosis was reported on August 20.
In this study, we report the clinical and epidemiologic features of a series of patients admitted to the PICU with a clinical diagnosis of LRTI subsequently confirmed as influenza A pH1N1 virus infection, and we compare them with patients with a non-pH1N1 respiratory virus infection.
Although many etiological agents may cause LRTI, RSV is the most frequently found, detected by immunofluorescence techniques. The findings of our study should be seen in this context. As shown in Table 1 , during the study period (2009), 48 children were admitted to the PICU with a diagnosis of acute LRTI due to viral causes. In 30 patients, the etiology was influenza A pH1N1. In 18 patients, an etiology other than influenza A pH1N1 was found: RSV in nine; adenovirus in one; and non-pH1N1 influenza A in eight. All 62 patients in group 2 of our study presented with LRTI due to a nonpH1N1 respiratory virus infection, of which RSV was the causative agent in 68%. Considering that in winter RSV is the most frequent etiology of LRTI and that in the current pandemic the number of patients with this virus is significantly lower, we could consider that pH1N1 virus infection has replaced infection by seasonal viruses.
Mortality and PICU stay were similar in both groups. However, some interesting differences could be observed in the comparison. Contrary to the common findings in patients admitted to the PICU because of LRTI due to non-pH1N1 influenza A, most of the children in group 1 were Ͼ2 yrs of age and, thus, had a higher weight. A possible explanation is that, at this age, children start attending daycare centers or kindergarten and is more exposed to respiratory infections. School activities are some of the major sources of exposure to the virus for children (14) . It is interesting to note that, between the two groups, some differences in the clinical diagnoses leading to PICU admission were found. Although bronchiolitis was the most common diagnosis in the group with non-pH1N1 respiratory virus infection, none of the children in group 1 presented with this syndrome at the time of admission to the unit. Contrarily, the children with influenza A pH1N1 infection more often presented with bilateral pneumonia and ARDS at the time of PICU admission. It is important to observe that, although many patients in group 1 presented with distributive shock on PICU admission, none of the children in group 2 did so and the difference was statistically significant.
MV was needed in both groups (in 96.6% and 98.4%, respectively), but in group 1, initial use of noninvasive positive-pressure ventilation was rare, whereas in group 2 it was used in 39 children. This is due to the fact that the children in group 1 were admitted in a more severe state and needed invasive mechanical respiratory assistance immediately. Only one patient in group 1, who was Ͻ3 months old, needed to receive extracorporeal membrane oxygenation because of ARDS after the use of MV, high-frequency ventilation, surfactant, and nitric oxide. Outcome was favorable in this child; after 12 days on extracorporeal membrane oxygenation, the child could be managed with conventional ventilation.
The children in both groups had a high prevalence of underlying medical conditions (83% and 79%, respectively); however, an important difference was found in the type of underlying pathology. In group 1, respiratory and neurologic diseases were more frequent.
Finally, when we compared mortality between both groups, no significant difference was found (6 of 30 and 11 of 62 patients, respectively). However, among the deceased patients in group 1, length of PICU stay was shorter than among those in group 2 (2.5 days and 14 days, respectively), and shock was the most common cause for admission (66% and 0%, respectively) (15) .
When reviewing studies published on influenza A pH1N1 infection in children, some data coincided with our findings, and some differed. Libster et al (8) did not give a detailed description of the group of patients admitted to the PICU, and they reported a higher mortality rate-27% of 47 children, most of them Ͻ2 yrs of age. In our study, mortality was 20%, and 58% of the children were Ͼ2 years of age. We have not found an explanation for these differences.
Lockman et al (9) described 13 children admitted to the PICU. As in our study, most of them had underlying chronic illness. Only 46% of their patients needed MV, but 23% required inotropic drugs, coinciding with 30% of our patients admitted to the PICU with shock. Similar to our series, O'Riordan et al (10) reported children Ͼ2 yrs of age infected by pH1N1 influenza, and they concluded that the infection did not seem to cause more severe disease than seasonal influenza A.
Jain et al (11) described 272 patients, 122 Ͻ18 years of age and the majority Ͼ2 yrs of age, and they also found a high number of children with underlying medical conditions, most frequently asthma and neurologic diseases.
Thus, it should be recommended that, in the winter, hospitals should have enough PICU beds prepared to receive critically ill children with influenza A pH1N1 respiratory virus infection.
Our study, however, does have some limitations. The patients assessed were all admitted to the PICU of a single, tertiarycare, referral center and are thus not representative of the total number of hospital admissions.
CONCLUSIONS
Patients with influenza A pH1N1 respiratory virus infection admitted to the PICU presented with more severe disease at the time of admission than those with non-pH1N1 respiratory virus infection, although mortality and length of PICU stay were similar.
